|Other names||EM-652; SCH-57068|
|Drug class||Selective estrogen receptor modulator|
|Chemical and physical data|
|Molar mass||457.570 g·mol−1|
|3D model (JSmol)|
Acolbifene (INN) (developmental code names EM-652, SCH-57068) is a nonsteroidal selective estrogen receptor modulator (SERM) which, as of 2015, is in phase III clinical trials for the treatment of breast cancer.
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|